FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

764774009: Conventional release and prolonged-release oral tablet (dose form)

Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3655031016 Conventional release and prolonged-release oral tablet en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3655032011 Conventional release and prolonged-release oral tablet (dose form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Conventional release and prolonged-release oral tablet Is a Prolonged-release oral tablet true Inferred relationship Some
Conventional release and prolonged-release oral tablet Is a Oral tablet true Inferred relationship Some
Conventional release and prolonged-release oral tablet Has dose form administration method (attribute) Swallow (administration method) true Inferred relationship Some
Conventional release and prolonged-release oral tablet Has dose form transformation (attribute) No transformation true Inferred relationship Some
Conventional release and prolonged-release oral tablet Has dose form intended site (attribute) Oral true Inferred relationship Some
Conventional release and prolonged-release oral tablet Has dose form release characteristic (attribute) Conventional release and prolonged-release true Inferred relationship Some
Conventional release and prolonged-release oral tablet Has basic dose form (attribute) Tablet true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Nicotinic acid 750 mg and simvastatin 20 mg prolonged-release oral tablet Has manufactured dose form False Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely nicotinic acid 500 milligram and simvastatin 20 milligram/1 each prolonged-release oral tablet (clinical drug) Has manufactured dose form False Conventional release and prolonged-release oral tablet Inferred relationship Some
Nicotinic acid 1 g and simvastatin 20 mg prolonged-release oral tablet Has manufactured dose form False Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely amlodipine (as amlodipine besilate) 5 milligram and indapamide 1.5 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Etoricoxib 90 mg and thiocolchicoside 8 mg conventional release and prolonged-release oral tablet Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely metoprolol tartrate (as metoprolol succinate) 50 milligram and telmisartan 40 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 50 mg conventional release and prolonged-release oral tablet Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Amlodipine (as amlodipine besilate) 5 mg and metoprolol tartrate (as metoprolol succinate) 25 mg conventional release and prolonged-release oral tablet Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely amlodipine (as amlodipine besilate) 2.5 milligram and metoprolol tartrate (as metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely levamlodipine (as levamlodipine besilate) 2.5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some
Product containing precisely levamlodipine (as levamlodipine besilate) 5 milligram and (S)-metoprolol tartrate (as (S)-metoprolol succinate) 25 milligram/1 each conventional release and prolonged-release oral tablet (clinical drug) Has manufactured dose form True Conventional release and prolonged-release oral tablet Inferred relationship Some

This concept is not in any reference sets

Back to Start